biases and benefit patient care, medical research, and trial recruitment. This study derived and internally validated text search algorithms to identify four common urological lesions (solid renal masses, complex renal cysts, adrenal masses, and simple renal cysts,) using radiology text reports.
INTRODUCTION AND OBJECTIVES: Multiparametric MRI has been widely used for local assessment of bladder cancer. In 2018, the Vesical Imaging-Reporting And Data System (VI-RADS) was proposed to standardize diagnostic criteria and report the risk of muscle-invasion (Panebianco et al. Eur Uro 2018) . A five-point VI-RADS score is generated using the individual structural category (SC), diffusionweighted (DW) category, and contrast-enhanced (CE) category. SC, DW, and CE categories were assessed using a five-point scale for T2-, DW-, and dynamic CE-(T2WI, DWI, and DCE) imaging, respectively. However, the diagnostic ability of VI-RADS has not been reported.
METHODS: Among the primary bladder cancer patients who were diagnosed with pT1 or higher urothelial carcinoma between 2009 and 2016, we retrospectively evaluated 115 (MIBC, n[ 46 [40%] ; NMIBC, n[ 69 [60%] ) who underwent MRI examination including DWI before TUR. The patients whose index bladder cancer was less than 10 mm on T2WI, and in whom muscle sampling was not performed were excluded from the analysis. MRI was performed using a 1.5-Tesla imager (Intera Achieva; Philips). One radiologist with 11 years of experience in reading abdominal DWI interpreted the imaging data. The index tumor was scored according to the VI-RADS in each patient. We compared VI-RADS scores with histological diagnosis for muscle invasion.
RESULTS: T2WI and DWI were obtained in all 115 patients, and DCE was performed in 87 of these patients (76%). The mean SC, DW, and CE category of NMIBC/MIBC was 3.1/4.5, 2.6/4.2 and 3.1/4.5, respectively. With a category threshold of 2, the negative predictive value (NPV) of T2W, DWI, and DCE was 95%, 95%, and 94%, respectively, while the positive predictive value (PPV) was low for all modalities (51-59%). If a category threshold of 3 was used, the PPV/ NPV/accuracy was 71/90/81% for T2W, 82/86/84% for DWI, and 81/86/ 79% for DCE, respectively. The area under the curve (AUC) for the diagnosis of muscle invasion was 0.83 for T2WI, 0.88 for DWI, and 0.84 for DCE. A VI-RADS score of T2WI þ DWI and T2WI þ DWI þ DCE resulted in AUCs of 0.88 and 0.86, respectively.
CONCLUSIONS: VI-RADS scoring is useful for bladder cancer staging. DWI was the leading sequence for accurately diagnosing muscle invasion. Combined use of DCE to T2WI and DWI did not necessarily increase detection accuracy of muscle invasion. METHODS: Patients with clinically significant (defined as ! 0.5 cm3 with Gleason pattern ! 4) localized prostate cancer(PCa) on conventional imaging modalities who planned to undergo surgery were imaged by PET/CT 90-120 minutes after 5AE2mCi of 68Ga-PSMA-11 injection and 2-4 days after 10mg IAB2M labeled with 2.5 mCi of 89Zr injection. Image results were read and mapped by a Nuclear Medicine MD without knowledge of the surgical pathology. Mapped findings were later compared with a surgical pathology map.
Source of Funding
RESULTS: 20 patients with median age 64.5 (46-79) and PSA 7.5(1.6-36.56) were enrolled. The first 11 patients were imaged only by IAB2M while last 9 patients were imaged by both IAB2M and PSMA-11. IAB2M detected 18 of 19 (95%) dominant lesions which had a median Gleason score 7.5 (6-9) in 19 patients; PSMA-11 detected 100% of dominant lesions with median Gleason score 8(6-9) in 8 patients. One patient refused surgery. The smallest dominant lesion detected was 8mm in size. The one dominant lesion missed by IAB2M was 7mm. Median SUVmax for dominant lesions was 3.1 (1.0-7.5) on IAB2M and 7.1 (1.6-23.2) on PSMA-11; median MR PIRADS was 4 (4-5). Of 17 Gleason 6 lesions identified on pathology, IAB2M detected 7 (41%) and of 9 lesions on pathology, PSMA-11 detected 3 (33%).
Extraprostatic lesions: in the first 11 patients who got only IAB2M, 3 patients had 7 extra-prostatic lesions; 4 extra-prostatic lesions were detected and confirmed by surgical path and 3 lesions were missed. In the subsequent 9 patients who got both PET scans, 4 extraprostatic lesions in one patient were detected by both PET agents, 3 were confirmed by surgical pathology and 1 confirmed on bone scan 2 months post-op. 15 false positive lesions were detected by IAB2M in 20 patients and 5 false positives were detected by PSMA-11 in the last 9 patients. There were 11 false negative lesions on IAB2M in all 19 patients and 3 false negatives on PSMA-11 in 8 patients. Of these false negatives, 7 were GS 6 and 2 were 3þ4 and LNs median size was 2mm (0.5-15).
CONCLUSIONS: In this small series, the performance of both PET agents was very similar. An advantage of IAB2M is its hepatobiliary rather than renal/urinary clearance, which makes it potentially easier to visualize the PCa and/or pelvic disease; an advantage of PSMA-11 is the ability to image within 1-2 hours. METHODS: A consecutive sample of men who underwent 18F-Fluciclovine PET/CT for biochemical recurrence at a single institution were included in this retrospective study. Patients were stratified into groups according to their serum PSA level (A: <0.5 ng/mL, B: 0.5-1.0 ng/mL, C: 1-1.5 ng/mL, D: 1.5-2.0 ng/mL, E: >2.0ng/mL) and the rate of scan positivity were compared between groups. Multivariable logistic regression analysis adjusting for patient, tumor and treatment charcteristics was performed to characterise the affect of PSA on yield. We also compared the SUVmax, SUVtotal and MTV between the groups.
RESULTS: A total of 76 patients with complete PSA data were included with 63.2% (n[48) having a positive 18F-Fluciclovine PET/ CT. The positivity rate for each of the groups were A: 0%, B: 66.7%, C: 70%, D: 72.7%, E: 78.4% (p<0.01). PSA acted as a significant predictor of positivity (OR 2.04 per unit increase, 95%CI 1.23-4.79). There was also a significant difference in SUVmax between the groups which increased with PSA levels (p[0.009). There was no difference in SUVtotal or MTV between the groups.
CONCLUSIONS: The yield of 18F-Fluciclovine PET/CT in patients with a PSA <0.5 ng/mL is low and therefore this scan should only be performed in patients with a PSA above this level.
Source of Funding: None
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⁶⁸GA-PSMA PET-CT AND MULTI-FREQUENCY-BAND RASTER-SCAN OPTOACOUSTIC MESOSCOPY AS IMAGING METHODS FOR RELAPSE DETECTION AND SUCCESS PREDICTION OF VASCULAR TARGETED PHOTODYNAMIC THERAPY IN A PROSTATE CANCER MODEL
Ricardo Alvim*, Katja Haedicke, Karan Nagar, Sudeep Das, Alexander Somma, New York, NY; Christopher Hughes, New york, NY; Avigdor Scherz, Rehovot, Israel; Kwanghee Kim, Jan Grimm, Jonathan Coleman, New York, NY INTRODUCTION AND OBJECTIVES: Limitations of standard assessments (MRI and PSA) used to follow patients with prostate cancer who receive focal therapy suggest that novel imaging approaches are needed. In this study, we assessed whether Gallium-68 PSMA PET-CT and multi-frequency-band raster-scan optoacoustic mesoscopy (RSOM) can be used to detect and predict relapse after vascular targeted photodynamic therapy (VTP) METHODS: 1Â106 LNCaP-AR cells were grafted in the flanks of 6-8 week old SCID mice (n[24). VTP (150 mW/cm2) was performed six weeks after implantation to ablate the tumor cells (n[20) . Control mice (n[4) did not receive VTP ablation. Blood PSA level assessment, 68 Ga-PSMA PET-CT, and RSOM images were performed 2 days before VTP and 1 and 3 weeks after. Mice were euthanized 4 weeks post-VTP and tumors were assessed by histology.
RESULTS: Of the 17 VTP-treated mice alive 4 weeks after ablation, 11 (65%) had completely ablated tumors and 6 (35%) had tumor relapse confirmed by histology. One week after VTP, mice that relapsed had an elevated PSMA PET-CT signal compared to very low in completely ablated tumors (p<0.01, Figure 1 ). Heat-Map Histogram analysis of pre-VTP RSOM data showed more intense signal in the ablation group than the relapse group (p[0.04) and lower vessels density in relapsed tumors (vessels/Tu area; p[0.03, Figure 2 ). PSA level was not useful for detecting relapse one week
